Ziziphora bungeana dripping pills, production method thereof and application of dripping pills as cardiovascular medicament

Abstract

The invention belongs to the technical field of medicine and relates to ziziphora bungeana dripping pills, a production method thereof and an application as a cardiovascular medicament. The ziziphora bungeana dripping pills are characterized by containing aromatic ziziphora bungeana total flavonoids and water-soluble pharmaceutical matrix, and the ratio of the water-soluble pharmaceutical matrix to the aromatic ziziphora bungeana total flavonoids in parts by weight is 1: 1 to 5: 1. The pharmacodynamic test result of the obtained ziziphora bungeana dripping pills shows that the ziziphora bungeana dripping pills have a protecting effect on myocardial ischemic injuries of rats, the anti-myocardial ischemia effect is greatly improved in comparison with the raw pharmaceutical material of the aromatic ziziphora bungeana total flavonoids, and the bioavailability and the clinical efficacy are improved. The obtained ziziphora bungeana dripping pills are convenient to use and good in patient compliance, and the production method is easy for industrialization.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a new Tahua dripping pill, a production method thereof and an application of cardiovascular drugs. Background technique [0002] Cardiovascular disease is a disease that seriously endangers human health. Studies have shown that in the next 20 years, due to population aging and population growth, the incidence of cardiovascular diseases in China will increase by more than 50%, and the increasing trend of high blood pressure, cholesterol and diabetes will lead to an additional increase of 23% in the incidence of cardiovascular diseases. Experts predict that if the current development trend is followed, the final result is that between the next and 2030, the number of patients with cardiovascular diseases in China will increase by 21.3 million, and the number of deaths from cardiovascular diseases will increase by 7.7 million. Therefore, in addition to surgical treatment, the task o...

AI Technical Summary

Problems solved by technology

[0006] The present invention provides a production method of Xintahua dripping pills, which overcomes the above-mentioned deficiencies in the prior art and solves the clinical administration of aromatic Xintahua total flavonoids The method and route of administration, the obtained Xintahua dripping pills have greatly improved the bioavailability of the aromatic Xintahua total flavonoids, and are especially suitable for application in the treatment of cardiovascular diseases